Mesoblast Ltd (ASX: MSB) Share Price and News
Price
Movement
52 Week Range
1 Year Return
() Chart and Price Data
Fundamental Company Figures
Data provided by Morningstar.Mesoblast Limited (ASX: MSB) Latest News
Why Mesoblast, Newcrest, Sezzle & Telstra shares are racing higher
James Mickleboro | February 11, 2021 11:40am
ASX 200 down 0.2%: Zip Chair steps down, Worley crashes, Blackmores & InvoCare jump
James Mickleboro | February 1, 2021 11:59am
Why Lynas, Mesoblast, ResMed, & Service Stream shares are pushing higher
James Mickleboro | January 29, 2021 11:38am
About Mesoblast Ltd (ASX: MSB)
Mesoblast is a small cap biotech company with listings on both the ASX and the Nasdaq. The company has acquired the rights to develop and commercialize certain regenerative medicine technologies aimed at innovative ways of treating inflammatory diseases. Of their product pipeline, three product candidates are currently in phase three trials, with the first drug in the FDA approval application process and a possible U.S. launch date in early fiscal 2021. The company has sold the rights to develop and commercialize some of its technologies in Japan, Europe and China from which it earns milestone and ongoing licence revenues once the products are marketed. Mesoblast is currently in the R&D phase and is loss-making.
Share Price History
Data provided by Morningstar.Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
09 Apr 2021 | $2.23 | $-0.04 | -1.76% | 1,528,036 | $2.26 | $2.27 | $2.21 |
08 Apr 2021 | $2.27 | $0.06 | 2.71% | 1,947,972 | $2.24 | $2.27 | $2.22 |
07 Apr 2021 | $2.21 | $-0.04 | -1.78% | 1,657,040 | $2.24 | $2.25 | $2.20 |
06 Apr 2021 | $2.25 | $0.03 | 1.35% | 1,911,617 | $2.20 | $2.27 | $2.19 |
01 Apr 2021 | $2.22 | $0.05 | 2.30% | 2,053,628 | $2.19 | $2.22 | $2.14 |
31 Mar 2021 | $2.17 | $0.01 | 0.46% | 2,144,486 | $2.17 | $2.19 | $2.13 |
30 Mar 2021 | $2.16 | $-0.06 | -2.70% | 2,577,457 | $2.23 | $2.27 | $2.14 |
29 Mar 2021 | $2.22 | $-0.06 | -2.63% | 1,689,052 | $2.29 | $2.31 | $2.22 |
26 Mar 2021 | $2.28 | $-0.05 | -2.15% | 2,531,376 | $2.32 | $2.35 | $2.26 |
25 Mar 2021 | $2.33 | $-0.06 | -2.51% | 1,702,492 | $2.35 | $2.39 | $2.32 |
24 Mar 2021 | $2.39 | $-0.08 | -3.24% | 1,811,617 | $2.44 | $2.45 | $2.38 |
23 Mar 2021 | $2.47 | $0.04 | 1.65% | 2,191,382 | $2.45 | $2.52 | $2.44 |
22 Mar 2021 | $2.43 | $0.01 | 0.41% | 1,174,267 | $2.42 | $2.46 | $2.40 |
19 Mar 2021 | $2.42 | $0.01 | 0.41% | 2,564,424 | $2.39 | $2.42 | $2.35 |
18 Mar 2021 | $2.41 | $-0.05 | -2.03% | 1,635,149 | $2.49 | $2.49 | $2.41 |
17 Mar 2021 | $2.46 | $-0.05 | -1.99% | 1,838,702 | $2.48 | $2.50 | $2.41 |
16 Mar 2021 | $2.51 | $0.07 | 2.87% | 3,525,606 | $2.46 | $2.52 | $2.39 |
15 Mar 2021 | $2.44 | $0.09 | 3.83% | 1,933,075 | $2.35 | $2.44 | $2.33 |
12 Mar 2021 | $2.35 | $0.08 | 3.52% | 2,584,719 | $2.29 | $2.35 | $2.26 |
Director Transactions
Data provided by Morningstar.Directors & Management
Data provided by Morningstar.Top Share Holders
Data provided by Morningstar.Name | Shares | Capital |
---|---|---|
J P Morgan Nominees Australia Pty Limited | 107,438,069 | 18.32% |
HSBC Custody Nominees (Australia) Limited | 103,290,771 | 17.61% |
Professor Silviu Itescu | 67,751,838 | 11.55% |
Citicorp Nominees Pty Limited | 13,318,990 | 2.27% |
UBS Nominees Pty Ltd | 11,101,280 | 1.89% |
National Nominees Limited | 10,653,027 | 1.82% |
Independent Asset Management Pty Limited | 7,870,558 | 1.34% |
BNP Paribas Nominees Pty Ltd | 6,203,700 | 1.06% |
Merrill Lynch (Australia) Nominees Pty Limited | 6,084,737 | 1.04% |
BNP Paribas Nominees Pty Ltd i | 4,986,283 | 0.85% |
Dalit Pty Ltd | 4,828,839 | 0.82% |
Mr Gregory John Matthews & Mrs Janine Marie Matthews | 3,956,219 | 0.67% |
CA Third Nominees Pty Limited | 3,832,425 | 0.65% |
Dalit Pty Ltd i | 2,195,000 | 0.37% |
Citicorp Nominees Pty Limited i | 2,077,360 | 0.35% |
Kentgrove Capital Pty Ltd | 2,000,100 | 0.34% |
BNP Paribas Noms Pty Ltd | 1,908,014 | 0.33% |
HSBC Custody Nominees (Australia) Limited Gsco Eca | 1,784,018 | 0.30% |
LALP Pty Ltd | 1,647,144 | 0.28% |
BNP Paribas Nominees Pty Ltd ii | 1,645,043 | 0.28% |